|
1
|
Sadock BJ, Sadock VA and Ruiz P: Kaplan
and Sadock's synopsis of psychiatry: Behavioral sciences/clinical
psychiatry. 11th edition. Wolters Kluwer Health, PA, 2015.
|
|
2
|
Marinescu I, Stovicek PO, Marinescu D and
Papacocea T: Cinnarizine-potential trigger of the dopamine
supersensitivity psychosis in patients with paranoid schizophrenia
particular neurobiochemical model. Rev Chim. 70:3003–3007.
2019.
|
|
3
|
Saha S, Chant D, Welham J and McGrath J: A
systematic review of the prevalence of schizophrenia. PLoS Med.
2(e141)2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Moreno-Küstner B, Martín C and Pastor L:
Prevalence of psychotic disorders and its association with
methodological issues. A systematic review and meta-analyses. PLoS
One. 13(e0195687)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lincă FI, Alexandrescu L, Cucu N and
Alexandrescu B: Investigation of FTO gene-BMI association in a
Romanian sample: A functional genomic interpretation. Biointerface
Res Appl Chem. 13(230)2023.
|
|
6
|
McClellan J and Stock S: American Academy
of Child and Adolescent Psychiatry (AACAP) Committee on Quality
Issues (CQI). Practice parameter for the assessment and treatment
of children and adolescents with schizophrenia. J Am Acad Child
Adolesc Psychiatry. 52:976–990. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murray RM, Bhavsar V, Tripoli G and Howes
O: 30 Years on: How the neurodevelopmental hypothesis of
schizophrenia morphed into the developmental risk factor model of
psychosis. Schizophr Bull. 43:1190–1196. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Davis J, Eyre H, Jacka FN, Dodd S, Dean O,
McEwen S, Debnath M, McGrath J, Maes M, Amminger P, et al: A review
of vulnerability and risks for schizophrenia: Beyond the two hit
hypothesis. Neurosci Biobehav Rev. 65:185–194. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hollis C and Palaniyappan L: Schizophrenia
and psychosis. In: Rutter's Child and Adolescent Psychiatry. Thapar
A, Pine DS, Leckman JF, Scott S, Snowling MJ and Taylor E (eds).
6th edition. Wiley, pp774-792, 2015.
|
|
10
|
Scherr M, Hamann M, Schwerthöffer D,
Froböse T, Vukovich R, Pitschel-Walz G and Bäuml J: Environmental
risk factors and their impact on the age of onset of schizophrenia:
Comparing familial to non-familial schizophrenia. Nord J
Psychiatry. 66:107–114. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Martínez-Ortega JM, Carretero MD,
Gutiérrez-Rojas L, Díaz-Atienza F, Jurado D and Gurpegui M: Winter
birth excess in schizophrenia and in non-schizophrenic psychosis:
Sex and birth-cohort differences. Prog Neuropsychopharmacol Biol
Psychiatry. 35:1780–1784. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chandra IS, Kumar KL, Reddy MP and Reddy
CMPK: Attitudes toward medication and reasons for non-compliance in
patients with schizophrenia. Indian J Psychol Med. 36:294–298.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
McGrath J, Brown A and St Clair D:
Prevention and schizophrenia-the role of dietary factors. Schizophr
Bull. 37:272–283. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu MQ, Sun WS, Liu BX, Feng GY, Yu L, Yang
L, He G, Sham P, Susser E, St Clair D and He L: Prenatal
malnutrition and adult schizophrenia: Further evidence from the
1959-1961 Chinese famine. Schizophr Bull. 35:568–576.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Flegr J, Príplatova L, Hampl R, Bicikovíá
M, Ripova D and Mohr P: Difference of neuro- and immunomodulatory
steroids and selected hormone and lipid concentrations between
Toxoplasma-free and Toxoplasma-infected but not CMV-free and
CMV-infected schizophrenia patients. Neuro Endocrinol Lett.
35:20–27. 2014.PubMed/NCBI
|
|
16
|
Müller N, Weidinger E, Leitner B and
Schwarz MJ: The role of inflammation in schizophrenia. Front
Neurosci. 9(372)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dorrington S, Zammit S, Asher L, Evans J,
Heron J and Lewis G: Perinatal maternal life events and psychotic
experiences in children at twelve years in a birth cohort study.
Schizophr Res. 152:158–163. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hosak L: New findings in the genetics of
schizophrenia. World J Psychiatry. 3:57–61. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Boydell J: Risk factors for schizophrenia.
Expert Rev Neurother. 1:183–191. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Semple DM, McIntosh AM and Lawrie SM:
Cannabis as a risk factor for psychosis: Systematic review. J
Psychopharmacol. 19:187–194. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hickman M, Vickerman P, Macleod J,
Kirkbride J and Jones PB: Cannabis and schizophrenia: Model
projections of the impact of the rise in cannabis use on historical
and future trends in schizophrenia in England and Wales. Addiction.
102:597–606. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tandon R, Keshavan MS and Nasrallah HA:
Schizophrenia, ‘just the facts’ what we know in 2008. 2.
Epidemiology and etiology. Schizophr Res. 102:1–18. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Morgan C and Fisher H: Environment and
schizophrenia: Environmental factors in schizophrenia: childhood
trauma-a critical review. Schizophr Bull. 33:3–10. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Clarke M, Whitty P, Browne S, McTigue O,
Kamali M, Gervin M, Kinsella A, Waddington JL, Larkin C and
O'Callaghan E: Untreated illness and outcome of psychosis. Br J
Psychiatry. 189:235–240. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Beckers T, Maassen N, Koekkoek B, Tiemens
B and Hutschemaekers G: Can social support be improved in people
with a severe mental illness? A systematic review and
meta-analysis. Curr Psychol. 42:14689–14699. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang CX, Ren XH, Yang XM, Fan RX, Wang Y,
Li YL, Jiang HJ, Liu YY and Liu X: Quality of life and its
influencing factors among schizophrenia patients living in urban
and rural areas. Sichuan Da Xue Xue Bao Yi Xue Ban. 54:608–613.
2023.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
27
|
Sher L and Kahn RS: Suicide in
schizophrenia: An educational overview. Medicina (Kaunas).
55(361)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mork E, Mehlum L, Barrett EA, Agartz I,
Harkavy-Friedman JM, Lorentzen S, Melle I, Andreassen OA and Walby
FA: Self-harm in patients with schizophrenia spectrum disorders.
Arch Suicide Res. 16:111–123. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chan MKY, Bhatti H, Meader N, Stockton S,
Evans J, O'Connor RC, Kapur N and Kendall T: Predicting suicide
following self-harm: Systematic review of risk factors and risk
scales. Br J Psychiatry. 209:277–283. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Crișan RM, Băcilă CI and Morar S: The role
of psychological autopsy in investigating a case of atypical
suicide in schizophrenia: A case report with a brief review of
literature. Egypt J Forensic Sci. 12(30)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Iliuta FP, Manea MC, Budisteanu M, Andrei
E, Linca F, Rad F, Cergan R and Ciobanu AM: Magnetic resonance
imaging of brain anomalies in adult and pediatric schizophrenia
patients: Experience of a Romanian tertiary hospital. Exp Ther Med.
22(1098)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Iliuta FP, Manea MC, Budisteanu M, Ciobanu
AM and Manea M: Magnetic resonance imaging in schizophrenia: Luxury
or necessity? (Review). Exp Ther Med. 22(765)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Diagnostic and statistical manual of
mental disorders: DSM-IV-TR. 4th edition. American Psychiatric
Association, Arlington, VA, 2009.
|
|
34
|
American Medical Association: ICD-10-CM
2022: The official codebook with guidelines. American Medical
Association, Chicago, 2021.
|
|
35
|
American Psychiatric Association and
American Psychiatric Association: Diagnostic and statistical manual
of mental disorders: DSM-5. 5th edition. American Psychiatric
Association, Washington, DC, 2013.
|
|
36
|
Raven JC: Raven Standard Progressive
Matrices, 2016. https://www.pearsonassessments.com/store/usassessments/en/Store/Professional-Assessments/Cognition-%26-Neuro/Raven’s-Progressive-Matrices-Second-Edition-%7C-Raven%27s-2/p/100001960.html.
Accessed Mar 22, 2018.
|
|
37
|
Hany M, Rehman B, Azhar Y and Chapman J:
Schizophrenia. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing, 2024.
|
|
38
|
Messias EL, Chen CY and Eaton WW:
Epidemiology of schizophrenia: Review of findings and myths.
Psychiatr Clin North Am. 30:323–338. 2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Allott KA, Schäfer MR, Thompson A, Nelson
B, Bendall S, Bartholomeusz CF, Yuen HP, McGorry PD, Schlögelhofer
M, Bechdolf A and Amminger GP: Emotion recognition as a predictor
of transition to a psychotic disorder in ultra-high risk
participants. Schizophr Res. 153:25–31. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Alelú-Paz R and Iturrieta-Zuazo I: Human
endogenous retroviruses: Their possible role in the molecular
etiology of the schizophrenia. Open J Genet. 2:70–76. 2012.
|
|
41
|
Brown AS and McGrath JJ: The prevention of
schizophrenia. Schizophr Bull. 37:257–261. 2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Insiyah I, Rohimah YT, Astuti SLD, Lestari
S, Suyanto S and Sulistyowati EC: Predicting quality of life of
schizophrenia patients. JKG. 8:22–32. 2023.
|
|
43
|
Ifteni P, Correll CU, Burtea V, Kane JM
and Manu P: Sudden unexpected death in schizophrenia: Autopsy
findings in psychiatric inpatients. Schizophr Res. 155:72–76.
2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chou IJ, Kuo CF, Huang YS, Grainge MJ,
Valdes AM, See LC, Yu KH, Luo SF, Huang LS, Tseng WY, et al:
Familial aggregation and heritability of schizophrenia and
co-aggregation of psychiatric illnesses in affected families.
Schizophr Bull. 43:1070–1078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Nyer M, Kasckow J, Fellows I, Lawrence EC,
Golshan S, Solorzano E and Zisook S: The relationship of marital
status and clinical characteristics in middle-aged and older
patients with schizophrenia and depressive symptoms. Ann Clin
Psychiatry. 22:172–179. 2010.PubMed/NCBI
|
|
46
|
Černis E, Vassos E, Brébion G, McKenna PJ,
Murray RM, David AS and MacCabe JH: Schizophrenia patients with
high intelligence: A clinically distinct sub-type of schizophrenia?
Eur psychiatr. 30:628–632. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Linca FI, Budisteanu M, Popovici DV and
Cucu N: The moderating role of emotional regulation on the
relationship between school results and personal characteristics of
pupils with attention deficit/hyperactivity disorder. Children
(Basel). 9(1637)2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cantor-Graae E, Pedersen CB, McNeil TF and
Mortensen PB: Migration as a risk factor for schizophrenia: A
Danish population-based cohort study. Br J Psychiatry. 182:117–122.
2003.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Selten JP and Cantor-Graae E: Hypothesis:
Social defeat is a risk factor for schizophrenia? Br J Psychiatry
Suppl. 51:s9–s12. 2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Torrey EF, Buka S, Cannon TD, Goldstein
JM, Seidman LJ, Liu T, Hadley T, Rosso IM, Bearden C and Yolken RH:
Paternal age as a risk factor for schizophrenia: How important is
it? Schizophr Res. 114:1–5. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Van Os J and Jones PB: Neuroticism as a
risk factor for schizophrenia. Psychol Med. 31:1129–1134.
2001.PubMed/NCBI View Article : Google Scholar
|
